Tag Archives: pipeline

What the NIH says about Bayh-Dole, 2

Posted on October 23, 2018 by Gerald Barnett

We are working through the NIH’s most recent misrepresentation of the Bayh-Dole Act. In the first part of this effort, we looked at the NIH’s bungling of the basic premise of Bayh-Dole and the concept of practical application. Bayh-Dole’s first … Continue reading →

Posted in Bayh-Dole, Commons, Open Source | Tagged , , , , | Comments Off on What the NIH says about Bayh-Dole, 2

Bayh-Dole’s preemption of public purposes to re-establish a patent monopoly pipeline

Posted on August 10, 2018 by Gerald Barnett

I wrote a Twitter thread in retweeting this observation. Erin (Eeks) Stair @DrErinkate Don’t forget about Bayh-Dole, passed in the 80s, which enabled the #NIH to use our tax dollars to fund drug research at institutions & businesses; allow them … Continue reading →

Posted in Bayh-Dole, History | Tagged , , , , , | Comments Off on Bayh-Dole’s preemption of public purposes to re-establish a patent monopoly pipeline

We are not talking about the rainbows

Posted on April 2, 2018 by Gerald Barnett

A while ago, Research Enterprise argued that the “manufactured substantially” requirement in Bayh-Dole, for all its gesture toward American manufacturing, is a nearly empty requirement. Absurdly narrow, easy to circumvent, waivable by federal agencies (“we tried and failed” or “we … Continue reading →

Posted in Bayh-Dole | Tagged , , , | Comments Off on We are not talking about the rainbows

Kill Bayh-Dole

Posted on October 18, 2017 by Gerald Barnett

The Bayh-Dole desperation continues. Now Bio has released its very own fakographic, citing impressive-sounding numbers with no foundation in fact, a fake history that exists in the minds of a few pundits, and perpetuates a fraud on the public that … Continue reading →

Posted in Bayh-Dole | Tagged , , , , , , | Comments Off on Kill Bayh-Dole